The company might just be the right kind of business operating at the right time in history.Veteran medical device maker Penumbra (PEN 4.55%) got a shot of good news on Wednesday. An analyst initiated coverage of the company's stock with a rather bullish review, and investors took this to heart. Collectively, they pushed Penumbra's share price up by almost 5% on a day when the S&P 500 index performed sluggishly with a 0.3% decline.Initiated with a buy recommendationJust after market close on Tuesday, Stifel ...

Alameda, CA-based Penumbra, Inc. (PEN) has secured the CE Mark in Europe for its newest computer-assisted vacuum thrombectomy (CAVT) technologies, Lightning Flash 2.0 and Lightning Bolt 7. Lightning Flash 2.0 is the most advanced mechanical thrombectomy system available to address venous and pulmonary thrombus while the Lightning Bolt 7 stands out as the most powerful arterial thrombectomy system in the market.The latest innovations further enhance the company’s neuro and vascular portfolios.Likely Trend of ...

"Based on outcomes from our clinical trials and from physicians using our devices globally, our CAVT technologies have greatly improved our ability to rapidly and safely remove clot in the vascular system," said James F. Benenati, M.D., FSIR, chief medical officer at Penumbra. "With quicker procedures and more efficient clot removal, we have improved outcomes while demonstrating a high level of safety. As adoption of thrombectomy becomes more widespread, Lightning Flash 2.0 and Lightning Bolt 7 will provide ...

A month has gone by since the last earnings report for Penumbra (PEN) . Shares have added about 20% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Penumbra due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Penumbra Q2 Earnings Miss, Gross Margin ContractsPenumbrare ...

ALAMEDA, Calif., Aug. 27, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 10, 2024.Event:     Baird Global Healthcare ConferenceDate:       Tuesday, September 10, 2024Time:      9:05am ET/6:05am PTA webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be ava ...

ALAMEDA, Calif., Aug. 21, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2024.Event: Wells Fargo Healthcare Conference Date: Wednesday, September 4, 2024 Time: 2:15pm ET/11:15am PT A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on t ...

asikkk/iStock via Getty Images Penumbra (NYSE:PEN) is a leader in the field of medical technology, with both vascular and neurological devices making a big splash in the improvement of care. The stock has been volatile over the past few years, with a peak of $340 in late June 2023 making way to a low of $148 recently. Now the shares are intriguing at $191/share as excitement for the new Lightning Flash and Thunderbolt are continuing to help drive revenue growth. They are both computed assisted vacuum th ...

To Include $100 Million Accelerated Share RepurchaseALAMEDA, Calif., Aug. 13, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced that its Board of Directors approved on August 5, 2024 a share repurchase authorization in the amount of up to $200 million, allowing Penumbra to repurchase its common stock from time to time at such prices as it deems appropriate through open market purchases, block transactions, privately negotiated transactions, including ...

ALAMEDA, Calif., Aug. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Growth Conference on Tuesday, August 13, 2024.Event:     Canaccord Genuity Growth ConferenceDate:       Tuesday, August 13, 2024Time:       9:00am ET/6:00am PTA webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be availab ...

For the quarter ended June 2024, Penumbra (PEN) reported revenue of $299.4 million, up 14.5% over the same period last year. EPS came in at $0.64, compared to $0.43 in the year-ago quarter.The reported revenue represents a surprise of +0.28% over the Zacks Consensus Estimate of $298.58 million. With the consensus EPS estimate being $0.56, the EPS surprise was +14.29%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expect ...